Innovative Therapies for Children with Cancer Consortium (ITCC)

ITCC is an academic European Consortium comprising a preclinical network of 9 research laboratories which specialises in paediatric tumour biology, pharmacology, as well as a clinical network of 34 paediatric oncology centres with specific expertise in the field of early drug development and clinical trials.  It runs clinical and translational research connecting new drugs, biology and the unmet needs of children with cancer. It also works closely with EMEA - the European Medicines Agency EMEA).

ITCC is a single European network with:

• 34 paediatric oncology centres with expertise in Phase I-II studies  
• 9 research laboratories specialising in tumour biology, phamacology, operating under a consortium agreement
• 6 European countries (France, UK, Italy, the Netherlands, Germany and Austria.)

For further information please visit the ITCC website.

SIOPE & ITCC

The collboration between SIOPE and ITCC is essential to further develop drugs beyond phase I and II and to appropriately address and conduct coordinated Paediatric Invesigation Plans (PIP) that will respond to unmet medical needs. Most ITCC members are SIOPE members.